These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

541 related articles for article (PubMed ID: 21572312)

  • 21. Urachal carcinomas of the nonglandular type: salient features and considerations in pathologic diagnosis.
    Paner GP; Barkan GA; Mehta V; Sirintrapun SJ; Tsuzuki T; Sebo TJ; Jimenez RE
    Am J Surg Pathol; 2012 Mar; 36(3):432-42. PubMed ID: 22301493
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumor-associated neoexpression of the pS2 peptide and MUC5AC mucin in primary adenocarcinomas and signet ring cell carcinomas of the urinary bladder.
    Kunze E; Krassenkova I; Fayyazi A
    Histol Histopathol; 2008 May; 23(5):539-48. PubMed ID: 18283638
    [TBL] [Abstract][Full Text] [Related]  

  • 23. GATA-3 immunohistochemistry in the differential diagnosis of adenocarcinoma of the urinary bladder.
    Ellis CL; Chang AG; Cimino-Mathews A; Argani P; Youssef RF; Kapur P; Montgomery EA; Epstein JI
    Am J Surg Pathol; 2013 Nov; 37(11):1756-60. PubMed ID: 24061521
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential diagnosis of bladder versus colorectal adenocarcinoma: keratin 7 and GATA3 positivity in nuclear ß-catenin-negative glandular tumours defines adenocarcinoma of the bladder.
    Broede A; Oll M; Maurer A; Siegert S; Stoerkel S; Golz R; Schwamborn K; Veeck J; Knuechel R; Gaisa NT;
    J Clin Pathol; 2016 Apr; 69(4):307-12. PubMed ID: 26463756
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The different morphologies of urachal adenocarcinoma do not discriminate genomically by micro-RNA expression profiling.
    Bissonnette ML; Kocherginsky M; Tretiakova M; Jimenez RE; Barkan GA; Mehta V; Sirintrapun SJ; Steinberg GD; White KP; Stricker T; Paner GP
    Hum Pathol; 2013 Aug; 44(8):1605-11. PubMed ID: 23528864
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mucinous carcinomas of the gallbladder: clinicopathologic analysis of 15 cases identified in 606 carcinomas.
    Dursun N; Escalona OT; Roa JC; Basturk O; Bagci P; Cakir A; Cheng J; Sarmiento J; Losada H; Kong SY; Ducato L; Goodman M; Adsay NV
    Arch Pathol Lab Med; 2012 Nov; 136(11):1347-58. PubMed ID: 23106580
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Detailed Immunohistochemical Analysis of a Large Series of Cervical and Vaginal Gastric-type Adenocarcinomas.
    Carleton C; Hoang L; Sah S; Kiyokawa T; Karamurzin YS; Talia KL; Park KJ; McCluggage WG
    Am J Surg Pathol; 2016 May; 40(5):636-44. PubMed ID: 26685087
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [CK7, CK20, SOX10 and CDX2: expressions and diagnostic values in primary adenocarcinoma of the sinonasal tract].
    Yue C; Piao Y; Bai Y; Liu H; Zhang L
    Zhonghua Yi Xue Za Zhi; 2015 Aug; 95(30):2447-50. PubMed ID: 26711206
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adenocarcinoma of urinary bladder: A report of two patients.
    Kumari N; Vasudeva P; Kumar A; Agrawal U
    J Cancer Res Ther; 2015; 11(4):1033. PubMed ID: 26881627
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cdx2, cytokeratin 20, thyroid transcription factor 1, and prostate-specific antigen expression in unusual subtypes of prostate cancer.
    Leite KRM; Mitteldorf CATS; Srougi M; Dall'Oglio MF; Antunes AA; Pontes J; Camara-Lopes LH
    Ann Diagn Pathol; 2008 Aug; 12(4):260-266. PubMed ID: 18620992
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adenocarcinoma of the urinary bladder.
    Roy S; Parwani AV
    Arch Pathol Lab Med; 2011 Dec; 135(12):1601-5. PubMed ID: 22129192
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The value of CDX2 and cytokeratins 7 and 20 expression in differentiating colorectal adenocarcinomas from extraintestinal gastrointestinal adenocarcinomas: cytokeratin 7-/20+ phenotype is more specific than CDX2 antibody.
    Bayrak R; Haltas H; Yenidunya S
    Diagn Pathol; 2012 Jan; 7():9. PubMed ID: 22268990
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Distinguishing primary adenocarcinoma of the urinary bladder from secondary involvement by colorectal adenocarcinoma: extended immunohistochemical profiles emphasizing novel markers.
    Rao Q; Williamson SR; Lopez-Beltran A; Montironi R; Huang W; Eble JN; Grignon DJ; Koch MO; Idrees MT; Emerson RE; Zhou XJ; Zhang S; Baldridge LA; Cheng L
    Mod Pathol; 2013 May; 26(5):725-32. PubMed ID: 23348900
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunohistochemistry in the differential diagnosis between primary and secondary intestinal adenocarcinoma of the urinary bladder.
    Raspollini MR; Nesi G; Baroni G; Girardi LR; Taddei GL
    Appl Immunohistochem Mol Morphol; 2005 Dec; 13(4):358-62. PubMed ID: 16280666
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinicopathologic features and utility of immunohistochemical markers in signet-ring cell adenocarcinoma of the bladder.
    Thomas AA; Stephenson AJ; Campbell SC; Jones JS; Hansel DE
    Hum Pathol; 2009 Jan; 40(1):108-16. PubMed ID: 18789486
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The value of SATB2 in the differential diagnosis of intestinal-type mucinous tumors of the ovary: primary vs metastatic.
    Perez Montiel D; Arispe Angulo K; Cantú-de León D; Bornstein Quevedo L; Chanona Vilchis J; Herrera Montalvo L
    Ann Diagn Pathol; 2015 Aug; 19(4):249-52. PubMed ID: 26059401
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunohistochemistry in the Diagnosis of Mucinous Neoplasms Involving the Ovary: The Added Value of SATB2 and Biomarker Discovery Through Protein Expression Database Mining.
    Strickland S; Wasserman JK; Giassi A; Djordjevic B; Parra-Herran C
    Int J Gynecol Pathol; 2016 May; 35(3):191-208. PubMed ID: 26535987
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunohistochemical study of neuroendocrine differentiation in primary glandular lesions and tumors of the urinary bladder.
    Bollito ER; Pacchioni D; Lopez-Beltran A; Volante M; Terrone C; Casetta G; Mari M; DePompa R; Cappia S; Papotti M
    Anal Quant Cytol Histol; 2005 Aug; 27(4):218-24. PubMed ID: 16220833
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Value of CDX2, villin, and alpha-methylacyl coenzyme A racemase immunostains in the distinction between primary adenocarcinoma of the bladder and secondary colorectal adenocarcinoma.
    Suh N; Yang XJ; Tretiakova MS; Humphrey PA; Wang HL
    Mod Pathol; 2005 Sep; 18(9):1217-22. PubMed ID: 15803184
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression analysis of kidney-specific cadherin in a wide spectrum of traditional and newly recognized renal epithelial neoplasms: diagnostic and histogenetic implications.
    Kuehn A; Paner GP; Skinnider BF; Cohen C; Datta MW; Young AN; Srigley JR; Amin MB
    Am J Surg Pathol; 2007 Oct; 31(10):1528-33. PubMed ID: 17895753
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.